'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides. [electronic resource]
Producer: 20120409Description: e27860 p. digitalISSN:- 1932-6203
- Animals
- Autoimmunity
- Cell Line
- Down-Regulation
- Encephalomyelitis, Autoimmune, Experimental -- immunology
- Epitopes -- immunology
- Female
- Humans
- Mice
- Mice, Inbred C57BL
- Multiple Sclerosis -- drug therapy
- Myelin Sheath -- immunology
- Peptides -- administration & dosage
- Protein Engineering -- methods
- Proteins -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.